Polygiene AB (POLYG) AI Stock Analysis

• Market Cap: €365.27M
• Dividend Yield: 2.85%
• Average Volume (3M): 6.20K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.77
• Revenue Growth: 7.92%
• EPS Growth: 94.99%
• Country: SE
• Employees: 37
• Sector: Consumer Cyclical
• Sector Strength: 84
• Industry: Chemicals - Specialty
• EPS (TTM): 0.05
• Shares Outstanding: 36,526,990
• 10 Day Avg. Volume: 5,228
• 30 Day Avg. Volume: 6,198
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: Hold
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 52 Neutral
• Price Target: kr9.00 ▲(0.00% Upside)

Polygiene AB's overall stock score is primarily impacted by its financial challenges, including negative profitability and cash flow issues. Technical analysis provides some positive momentum, but valuation concerns due to negative earnings weigh heavily on the score.

Polygiene AB Business Overview & Revenue Model

Company Description

Polygiene Group AB develops, manufactures, and sells odor control and stay fresh solutions for clothes, sports equipment, textiles, and other materials in the Middle East, Africa, the Asia Pacific, the Americas, Europe, and internationally. It serves partners in the categories of sports and outdoor, fashion and lifestyle, workwear, hospitality, home and pets, healthcare, water, industrial, and paper and packaging. The company offers its products under the Polygiene brand. The company was formerly known as Polygiene AB (publ.) and changed its name to Polygiene Group AB in June 2022. Polygiene Group AB was founded in 2005 and is headquartered in Malmö, Sweden.

How the Company Makes Money

Polygiene generates revenue primarily through the sale of its antimicrobial and odor control treatments to various industries, including apparel, home textiles, and sports equipment. The company licenses its technology to manufacturers who incorporate Polygiene's treatments into their products, allowing them to command a premium price due to the added value of enhanced durability and hygiene. Key revenue streams include direct sales to textile manufacturers, licensing agreements with brands, and royalties from products that feature Polygiene's technology. Additionally, partnerships with leading global brands in the fashion and sports sectors contribute significantly to Polygiene's earnings, as these collaborations often lead to increased product visibility and demand.

Polygiene AB Financial Statement Overview

Summary

Polygiene AB faces several financial challenges. Despite a strong gross profit margin and low leverage, the company struggles with profitability and cash flow generation. The negative net profit margin and declining revenue growth highlight operational difficulties.

Income Statement

Polygiene AB's income statement shows mixed results. The gross profit margin remains strong at 66.9% for TTM, indicating efficient cost management. However, the net profit margin is negative at -6.5%, reflecting challenges in profitability. Revenue growth has declined by 2.3% TTM, signaling potential market or operational issues. The EBIT and EBITDA margins have also decreased, suggesting reduced operational efficiency.

Balance Sheet

The balance sheet of Polygiene AB is relatively stable with a low debt-to-equity ratio of 0.011, indicating minimal leverage and financial risk. However, the return on equity is negative at -3.6% TTM, pointing to inefficiencies in generating returns for shareholders. The equity ratio is healthy, showing a strong capital structure.

Cash Flow

Cash flow analysis reveals significant challenges. Free cash flow has decreased by 79.4% TTM, indicating potential liquidity issues. The operating cash flow to net income ratio is low at 0.22, suggesting difficulties in converting earnings into cash. Despite a positive free cash flow to net income ratio, the overall cash flow position is weak.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	166.40M	156.95M	113.54M	173.56M	181.61M	83.93M
Gross Profit	111.31M	103.78M	77.16M	114.57M	115.24M	56.53M
EBITDA	13.81M	18.80M	-305.61M	19.10M	43.99M	701.00K
Net Income	-10.89M	16.83M	-321.95M	8.36M	32.83M	-1.74M
Balance Sheet
Total Assets	320.00M	350.84M	313.78M	621.90M	550.69M	57.64M
Cash, Cash Equivalents and Short-Term Investments	47.39M	68.59M	44.15M	48.06M	52.40M	4.33M
Total Debt	3.27M	2.63M	3.89M	1.64M	2.40M	1.66M
Total Liabilities	25.35M	31.23M	22.53M	29.34M	31.54M	30.16M
Stockholders Equity	294.65M	319.61M	291.25M	592.56M	519.15M	27.48M
Cash Flow
Free Cash Flow	3.37M	22.75M	-4.27M	-50.64M	34.15M	1.03M
Operating Cash Flow	5.05M	24.34M	3.79M	-1.54M	37.60M	2.92M
Investing Cash Flow	-2.05M	-1.59M	-9.42M	-52.11M	-407.47M	-4.04M
Financing Cash Flow	-6.58M	-1.38M	1.95M	47.50M	416.27M	694.00K

Polygiene AB Technical Analysis

• Technical Analysis Sentiment: Neutral
• Last Price: 9.00
• 50DMA: Positive
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:POLYG, the sentiment is Neutral. The current price of 9 is below the 20-day moving average (MA) of 9.02, above the 50-day MA of 8.66, and below the 200-day MA of 10.53, indicating a neutral trend. The MACD of 0.29 indicates Negative momentum. The RSI at 56.06 is Neutral, neither overbought nor oversold. The STOCH value of 83.25 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for SE:POLYG.

Polygiene AB Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	61 Neutral	$18.38B	12.79	-2.54%	3.03%	1.52%	-15.83%
AXIC.A	59 Neutral	kr154.88M	―	-32.52%	―	64.85%	44.62%
POLYG	52 Neutral	€365.27M	-24.18	-5.04%	2.85%	7.92%	94.99%
NEXAM	46 Neutral	€254.88M	-17.80	-7.96%	―	-1.89%	-59.17%
TRIBO.B	46 Neutral	kr41.36M	―	-17.94%	―	9.05%	81.56%
LCLEAN	41 Neutral	kr35.09M	―	-354.88%	―	-15.74%	44.98%
ORGC	41 Neutral	€195.81M	-7.67	-75.16%	―	-18.29%	-48.74%